Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Conditions:   Triple-negative Breast Cancer;   NSCLC, Squamous or Non-Squamous;   Urothelial Carcinoma of the Bladder;   Microsatellite Stable (MSS) Colorectal Cancer (CRC);   Cervical Cancer
Interventions:   Drug: AN0025;   Drug: Pembrolizumab
Sponsor:   Adlai Nortye Biopharma Co., Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2020 / by / in
Comments